Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00966667|
Recruitment Status : Active, not recruiting
First Posted : August 27, 2009
Last Update Posted : August 9, 2018
RATIONALE: Gathering information over time from patients who have finished treatment for colorectal cancer may help doctors predict which cancer survivors will improve their physical activity and diet.
PURPOSE: This clinical trial is studying health behaviors in patients who have finished treatment for stage I, stage II, or stage III colorectal cancer.
|Condition or disease|
- To characterize patterns and identify predictors of post-treatment physical activity and dietary changes made by colorectal cancer survivors.
- To identify the affective and cognitive effects of post-treatment physical activity and dietary changes in these patients.
- To identify these patients' preferences regarding diet and physical activity health promotion programs.
OUTLINE: This is a multicenter study.
Patients complete surveys at baseline and at 3 and 6 months. A randomly selected subset of 84 patients also receive an activity monitor to be use at each of the 3 time points. The acceptability of their use is assessed and whether activity levels change across the 3 time points and the extent to which they are convergent with self-reported physical activity are examined.
During each survey, questionnaires are administered to assess the following areas: physical/medical characteristics (self-reported), self-efficacy for physical activity, fruit and vegetable consumption, and dietary fat intake; outcome expectations for physical activity, fruit and vegetable consumption, and dietary fat intake; physical activity and diet behavioral self-regulation; illness representations (causal attributions and controllability of recurrence); perceived risk of colorectal cancer (CRC) recurrence; emotional representations of CRC (cancer-related anxiety and worry about cancer recurrence); healthcare provider recommendations to alter physical activity and dietary intake; social influence from important others; current physical activity and dietary intake; and diet and physical activity program preferences. Patients who received the activity monitor are asked feedback on acceptability of them.
Measures of sociodemographics and disease/treatment characteristics (via medical chart review) are recorded.
|Study Type :||Observational|
|Estimated Enrollment :||222 participants|
|Observational Model:||Ecologic or Community|
|Official Title:||Health Behaviors Among Individuals Diagnosed With Colorectal Cancer|
|Study Start Date :||November 2009|
|Estimated Primary Completion Date :||August 2019|
|Estimated Study Completion Date :||August 2019|
- Self-efficacy for changing physical activity and dietary practices [ Time Frame: 3 yrs ]
- Outcome expectations with regard to physical activity and dietary practices [ Time Frame: 3 yrs ]
- Behavioral self-regulation of physical activity and dietary practices [ Time Frame: 3 yrs ]
- Perceived role of physical activity and dietary factors in causing colorectal cancer (CRC) and preventing recurrence (CRC illness representations) [ Time Frame: 3 yrs ]
- Perceived risk of CRC recurrence [ Time Frame: 3 yrs ]
- Cancer-related anxiety and worry about cancer recurrence (emotional representations of CRC) [ Time Frame: 3 yrs ]
- Receipt of healthcare provider recommendations to alter physical activity and diet [ Time Frame: 3 yrs ]
- Normative influences of family and friends [ Time Frame: 3 yrs ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00966667
|United States, New Jersey|
|Cooper Hospital/University Medical Center|
|Camden, New Jersey, United States, 08103|
|JFK Medical Center in Edison|
|Edison, New Jersey, United States, 08818|
|Centrastate Healthcare System|
|Freehold, New Jersey, United States, 07728|
|Robert Wood Johnson University Hospital at Hamilton|
|Hamilton, New Jersey, United States, 08690|
|Montclair, New Jersey, United States, 07042|
|Morristown Medical Center|
|Morristown, New Jersey, United States, 07962|
|Jersey Shore University Medical Center|
|Neptune, New Jersey, United States, 07754|
|Rutgers Cancer Institute of New Jersey|
|New Brunswick, New Jersey, United States, 08903|
|Saint Peters University Hospital|
|New Brunswick, New Jersey, United States, 08903|
|University Medical Center at Princeton|
|Princeton, New Jersey, United States, 08540|
|Robert Wood Johnson University Hospital Somerset|
|Somerville, New Jersey, United States|
|Overlook Medical Center|
|Summit, New Jersey, United States, 07901|
|United States, Pennsylvania|
|Fox Chase Cancer Center|
|Philadelphia, Pennsylvania, United States|
|United States, Texas|
|MD Anderson Cancer Center|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Elliot Coups, PhD||Rutgers Cancer Institute of New Jersey|